NCT06577272View on ClinicalTrials.gov

Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients

RecruitingOBSERVATIONAL

Enrollment

6,000

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions

Hepatocellular Carcinoma

Trial Locations (1)

310003

RECRUITING

The First Affiliated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors

lead

Tian'an Jiang

OTHER